Testing effectiveness (Phase 2)Study completedNCT00289185
What this trial is testing
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 340